Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade
Cécile Gstalder, David Liu, Diana Miao, et al.
Cancer Discovery (2020) Vol. 10, Iss. 9, pp. 1296-1311
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis
Raymond Chen, Charles A. Ishak, Daniel D. De Carvalho
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2707-2725
Open Access | Times Cited: 131
Clinical significance of FBXW7 loss of function in human cancers
Jingyi Fan, Marcia Bellon, Mingyi Ju, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 88
Base editing screens map mutations affecting interferon-γ signaling in cancer
Matthew A. Coelho, Sarah Cooper, Magdalena E. Strauß, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 288-303.e6
Open Access | Times Cited: 54
A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors
Keigo Chida, Akihito Kawazoe, Masahito Kawazu, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 13, pp. 3714-3724
Open Access | Times Cited: 88
Targeting ubiquitin signaling for cancer immunotherapy
Xiaofei Zhou, Shao‐Cong Sun
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 58
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
Stephanie Pei Tung Yiu, Cassie Zerbe, David Vanderwall, et al.
Molecular Cell (2023) Vol. 83, Iss. 13, pp. 2367-2386.e15
Open Access | Times Cited: 26
RIG-I-like receptors: Molecular mechanism of activation and signaling
Jie Zheng, Wenjia Shi, Ziqun Yang, et al.
Advances in immunology (2023), pp. 1-74
Closed Access | Times Cited: 23
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
Daniel S. Lefler, Steven Manobianco, Babar Bashir
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 15
The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance
Justin L. Engel, Xiao Zhang, Mingming Wu, et al.
Cell (2024) Vol. 187, Iss. 21, pp. 6055-6070.e22
Closed Access | Times Cited: 11
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma
Julia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 308-316.e6
Open Access | Times Cited: 1
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
Riyue Bao, Daniel Stapor, Jason J. Luke
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 55
METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
Yingtong Wu, Ning Chang, Yong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 46
The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
Rongrong Zhao, Boyan Li, Shouji Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Activation of γ-globin expression by hypoxia-inducible factor 1α
Ruopeng Feng, Thiyagaraj Mayuranathan, Peng Huang, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 783-790
Open Access | Times Cited: 36
Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
Ping Shuai, Siyuan Wang, Yingsong Zhao, et al.
Cancer Medicine (2022) Vol. 11, Iss. 18, pp. 3529-3541
Open Access | Times Cited: 31
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Siyu Chen, Ping Leng, Jinlin Guo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 17
Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase
Yihang Qi, Abdol-Hossein Rezaeian, Jingchao Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189140-189140
Closed Access | Times Cited: 5
RETRACTED: A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells
Jia Shen, Zhixin Qiu, Qiulian Wu, et al.
Molecular Cell (2022) Vol. 82, Iss. 6, pp. 1123-1139.e8
Open Access | Times Cited: 21
To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations
Ruoxue Cai, Hongyu Zhu, Ying L. Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 10027-10040
Open Access | Times Cited: 12
Noncanonical MAVS signaling restrains dendritic cell–driven antitumor immunity by inhibiting IL-12
Lingling Wu, Xiaochuan Hong, Chao Yang, et al.
Science Immunology (2023) Vol. 8, Iss. 90
Closed Access | Times Cited: 12
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B. Fox, Richard Y. Ebright, Xin Hong, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p/FBXW7/HSF1 axis under hypoxic microenvironment
Zhanliang Liu, Zhemin Lin, Mingxin Jiang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 698-709
Closed Access | Times Cited: 4
Melanoma genomics – will we go beyond BRAF in clinics?
Justyna Mirek, Wiesław Bal, Magdalena Olbryt
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top